Intelligent Bio Solutions Inc.
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · New York, NY
INBS chart
What traders are saying about $INBS
Latest postsIntelligent Bio Solutions Inc. news
- Intelligent Bio Solutions earnings beat by $0.45, revenue fell short of estimates
Investing.com ·
- Intelligent Bio Solutions Reports Q1 FY2027 Revenue Increase to $1.39 Million with Reduced Net Loss
Kalkine Media ·
- Despite a roughly $5M raise, Intelligent Bio Solutions (INBS) needs more funding.
Stock Titan ·
- Intelligent Bio Solutions Reports Record Fiscal First Quarter 2027 Revenue of $1.39 Million, Marking Sixth Consecutive Quarter of Year-Over-Year Growth
Yahoo Finance ·
- Intelligent Bio Solutions to Present at the Webull Biotech Webinar on November 12
Yahoo Finance ·
- A company that screens for drugs through fingerprints will take questions live online
Stock Titan ·
- Intelligent Bio Solutions to present at Webull Biotech Webinar on Nov 12
Pluang ·
- Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET
Yahoo Finance ·
- Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market
Yahoo Finance ·
- Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance
Yahoo Finance ·
- Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission
Yahoo Finance ·
- Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules
Yahoo Finance ·
Intelligent Bio Solutions Inc. key financials
| USD | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $4.2M | $3.1M | $3.1M | $1.3M |
| Net income | -$12.5M | -$10.6M | -$10.2M | -$10.6M |
| Diluted EPS | $-8.44 | $-20.04 | $-6.38 | $-127.00 |
| Total assets (year end) | – | $17.7M | $8.7M | $8.8M |
| Cash and equivalents (year end) | – | $740,371 | $2.2M | $1.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Intelligent Bio Solutions Inc.
- Ticker
- INBS (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- June 30
- SEC CIK
- 1725430
- Former names
- GBS Inc., Glucose Biosensor Systems (Greater China) Holdings, Inc.
Frequently asked questions
What exchange is Intelligent Bio Solutions Inc. listed on?
Intelligent Bio Solutions Inc. trades on the Nasdaq under the ticker symbol INBS.
What industry is Intelligent Bio Solutions Inc. in?
Intelligent Bio Solutions Inc. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is Intelligent Bio Solutions Inc. headquartered?
Intelligent Bio Solutions Inc.'s business address on file with the SEC is in New York, NY.
When does Intelligent Bio Solutions Inc.'s fiscal year end?
Intelligent Bio Solutions Inc.'s fiscal year ends on June 30.
How much revenue did Intelligent Bio Solutions Inc. report?
Intelligent Bio Solutions Inc. reported $4.2M in revenue for calendar year 2026, according to its SEC filings.